glp-1 agonist brand names receptor Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market Report 10 GLP-1 Agonist Medications For
Description
Novo Nordisk offers similar programs for Wegovy

The modified peptide contains 2 Aib substitutions at positions 2 and 20 with a molecular weight of 4.5 kDa

4 Interestingly, early trials suggested DPP-4 may affect the immune system due to inhibition of T-cell activity in vitro

Slowing Down Digestion: These injections activate receptors in the stomach to slow the digestion process, which helps in better nutrient absorption and reduces post-meal glucose spikes, contributing to gradual blood sugar levels and aiding in weight management
A study involving 1,961 individuals found that, on average, people who received injections of semaglutide (the chemical name for Wegovy) lost 14.9 percent of their initial body weight over 68 weeks compared with just 2.4 percent for a group receiving placebo injections

UPDATE 3-US FDA sees pancreatitis link with Merck's Januvia [article online], Reuters, 25 September 2009
